FDA Approves Cervarix Vaccine for Girls
Links shared publicly online about this topic
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine
drugs.com — “Cervarix (Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) is used for prevention of cervical cancer. Includes Cervarix side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 16, 2009 at 10:45 pm By:
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine - http://bit.ly/2Y6rH0
FDA approves two HPV vaccines: Cervarix for girls, Gardasil for boys | Oral Cancer News
oralcancernews.org — “FDA approves two HPV vaccines: Cervarix for girls, Gardasil for boys | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on October 21, 2009 at 5:42 pm By:
The Oral Cancer Foundation Health Organization
FDA approves two HPV vaccines: Cervarix for girls, Gardasil for boys: http://bit.ly/4vCFDt
FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine | Reuters
reuters.com — “PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX [Human papillomavirus bivalent (types” View full resource at reuters.com
Most Recently Shared on October 16, 2009 at 4:16 pm By:
Skin & Allergy News Health News
RT @Apfeiffer: RT @cancercures: FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine http://bit.ly/3PBG9D
FDA Considers New HPV Vaccine Cervarix
webmd.com — “An fda advisory panel is set to discuss a second hpv vaccine called cervarix to help prevent cervical cancer.” View full resource at webmd.com
Most Recently Shared on September 8, 2009 at 8:17 pm By:
FDA Considers New HPV Vaccine Cervarix: An FDA advisory panel is set to discuss a second HPV vaccine called Cerv.. http://bit.ly/2D48w9
FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent [Updated] | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “The food and drug administration today approved cervarix, the vaccine against human papilloma virus (hpv) manufactured by glaxosmithkline, for use in girls and young women ages 10 to 25. an fda adivsory panel recommended approval of the vaccine on sept....” View full resource at latimesblogs.latimes.com
Most Recently Shared on October 16, 2009 at 4:10 pm By:
LA Times Health News Health News
FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent http://bit.ly/3NhY9x
News Blog: FDA panel approves Gardasil HPV vaccine for males, and competing Cervarix might hit shelves soon
scientificamerican.com — “Vaccines for the human papillomavirus (hpv) might not be just for girls anymore. a medical advisory panel for the u.s. food and drug administration (fda) voted today that the use of gardasil to prevent hpv, a sexually transmitted disease , in males ages ” View full resource at scientificamerican.com
Most Recently Shared on September 9, 2009 at 11:14 pm By:
Scientific American Health Magazine
FDA panel approves Gardasil HPV vaccine for males, and competing Cervarix might hit shelves soon: Vaccines for t.. http://bit.ly/qyK7L
FDA Approves New Vaccine for Prevention of Cervical Cancer
fda.gov — “The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.” View full resource at fda.gov
Most Recently Shared on October 19, 2009 at 4:49 pm By:
Gannett Healthcare Health News
FDA Approves Cervarix Vaccine for Prevention of Cervical Cancer: http://bit.ly/3aQ67b
FDA backs new cervical cancer vaccine Cervarix - Sexual health- msnbc.com
msnbc.msn.com — “Federal health officials favor approving GlaxoSmithKline's long-delayed vaccine Cervarix to prevent the leading cause of cervical cancer in U.S. women.” View full resource at msnbc.msn.com
Most Recently Shared on September 9, 2009 at 6:42 pm By:
msnbc.com - Health Health News
FDA backs new cervical cancer vaccine Cervarix http://bit.ly/VTzE3
Cervarix approved for prevention of HPV-associated cervical cancer - MPR
empr.com — “The FDA has approved Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant, from GlaxoSmithKline) for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and women 10"25 years of age.” View full resource at empr.com
Most Recently Shared on October 16, 2009 at 8:55 pm By:
MPR News: Cervarix approved for prevention of HPV-associated cervical cancer: The FDA has approved Cerv.. http://bit.ly/WF8uF
FDA Approves Two HPV Vaccines
injuryboard.com — “Cervarix has been approved for use in girls and women to fight cervical cancer the FDA announced on Friday the same day that Gardasil got approval for expanded use in boys and men to fight genital warts” View full resource at injuryboard.com
Most Recently Shared on October 21, 2009 at 9:26 pm By:
UT Southwestern News Medical School
2 #HPV vaccines okayed by #FDA. UTSW pediatric infectious disease expert comments on the decision. http://bit.ly/1NiIDZ
FDA Approves Two HPV Vaccines
news.injuryboard.com — “Cervarix has been approved for use in girls and women to fight cervical cancer the FDA announced on Friday the same day that Gardasil got approval for expanded use in boys and men to fight genital warts” View full resource at news.injuryboard.com
Most Recently Shared on October 21, 2009 at 10:57 pm By:
RT @UTSWNews 2 #HPV vaccines okayed by #FDA. UTSW pediatric infectious disease expert comments on the decision. http://bit.ly/1NiIDZ
FDA delays decision on Cervarix; GSK recalls vaccine in U.K. - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA delayed again its decision to approve cervical cancer vaccine Cervarix to further review GlaxoSmithKline's application. The agency's announcement came the same day GSK recalled a batch of Cervarix in the U.K. because a 14-year-old girl died after getting vaccinated. <a href='/servlet/aaRedir” View full resource at smartbrief.com
Most Recently Shared on October 1, 2009 at 1:49 am By:
Clara Song Pediatrician, Physician, and Doctor
FDA delays decision on Cervarix; GSK recalls vaccine in U.K. http://sbne.ws/r/2UZl
FDA Clears Glaxo's Cervarix Vaccine - WSJ.com
online.wsj.com — “U.S. regulators approved GlaxoSmithKline's Cervarix vaccine designed to protect against cervical cancer in women.” View full resource at online.wsj.com
Most Recently Shared on October 16, 2009 at 9:09 pm By:
FDA Clears Glaxo's Cervarix Vaccine http://bit.ly/oNPcN
FDA Clears Glaxo's Cervarix Vaccine - WSJ.com
online.wsj.com — “U.S. regulators approved GlaxoSmithKline's Cervarix vaccine designed to protect against cervical cancer in women.” View full resource at online.wsj.com
Most Recently Shared on October 16, 2009 at 4:40 pm By:
FDA Clears Glaxo's Cervarix Vaccine http://bit.ly/1H4x1
FDA approves second cervical cancer vaccine, Cervarix, for preventing HPV in women
nydailynews.com — “Federal health officials said Wednesday a long-delayed vaccine from GlaxoSmithKline successfully blocks the leading virus that causes cervical cancer in women.” View full resource at nydailynews.com
Most Recently Shared on September 10, 2009 at 3:34 pm By:
FDA backs new HPV vaccine, Cervarix: Federal health officials said Wednesday a long-delayed vaccine from GlaxoSm.. http://bit.ly/30QPTi
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
The Oral Cancer Foundation
Information- Support- Advocacy- Research- Hope The foundation is an IRS registered non-profit 501(c) 3, public service charity designed for advocacy and service, created to promote change, through proactive means, in both the public and medical/dental professional sectors. At the forefront of our agenda is the firm establishment in the minds of the American public for the need to undergo an annual oral cancer screening, combined with an outreach to the dental and medical communities to provide this service as a matter of routine practice. Oral cancer takes more lives than cancers we routinely hear about, such as cervical, Hodgkin's lymphoma, skin (malignant melanoma), testicular, and many others. In the efforts to reduce the death rate from cancers in the US, the most significant progress has been made through early detection. Cervical, skin, prostate, and others that lend themselves to simple, opportunistic screenings and exams have all had their death rates reduced through programs promoting early discovery. Early discovery and diagnosis, yields better long-term outcomes, and lower morbidity to those who undergo treatments. Oral cancer is not hidden within the body in some hard to find location requiring an invasive examination, the majority of the time it is literally in plain view, right under your nose, and can be seen with the naked eye or felt with the fingers. In most cases, its early, highly survivable stages are easily detected in a 3 to 5 minute painless visual and tactile examination. Even the precancerous lesions, which can progress into malignancy, can be seen with the naked eye. An annual oral examination conducted by members of the dental and medical communities will have a definite impact on reducing the death rate associated with oral cancer. It is our mission to bring this about.
-
Skin & Allergy News
The leading independent newspaper for medical, surgical, and aesthetic dermatology.
Advertisement
